Samsung Medical Center
Gallbladder cancer treatment cost in the Republic of Korea typically includes essential diagnostics like a PET/CT scan running from $1,000 to $1,500. Primary treatment options often involve advanced therapies such as proton-beam therapy, which ranges from $22,000 to $45,000, or brachytherapy costing $11,800 to $21,000. Total expenses depend on the cancer stage, hospital tier, and chosen technology. Patients typically find 30-50% savings compared to the US, with top care centered in Seoul and Incheon.
Typical Gallbladder Cancer Treatment Costs in Republic of Korea
Bookimed Expert Insight: For complex cases, choosing high-volume centers like Seoul National University Hospital ensures access to the highest cancer treatment statistics. Patients seeking minimal scarring should consider Korea University Anam Hospital, which pioneered robotic surgical methods. Samsung Medical Center provides elite care with advanced technologies like Novalis and Da Vinci systems. Digitalized facilities like SNUBH effectively minimize medical errors for high-risk abdominal surgeries.
| Republic of Korea | Turkey | Austria | |
| Proton-beam therapy | from $22,000 | from $70,000 | from $80,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Brachytherapy | from $11,800 | from $3,465 | from $15,000 |
| Proton therapy for prostate cancer | - | from $30,000 | from $80,000 |
| Proton therapy for breast cancer | - | from $30,000 | from $55,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Gallbladder cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Gallbladder cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Gallbladder cancer treatment journey.
The doctor is a leading breast cancer specialist in South Korea and is recognized among the world’s top 100 gastric and breast cancer surgeons. The doctor pioneered breast conserving surgery in South Korea in 1986 and invented a unique stomach cancer surgery that minimizes the risk of gastroesophageal reflux disease. The doctor currently heads the Cancer Center for Women at Ewha Womans University Medical Center and has previously served as President of Konkuk University Hospital and Director of Korea Cancer Center Hospital. The doctor is also an active researcher in breast cancer diagnosis and management.
The doctor is a leading gastroenterologist in South Korea and Asia, specializing in the management of pancreatic, bile duct, and gallbladder cancers, as well as pancreatitis and gallstones.
Currently practicing at Samsung Medical Center, the doctor has an educational background from The Seoul National University College of Medicine and The University of California.
The doctor is an active member of several professional organizations, including The Korean Society of Gastrointestinal Endoscopy, The Korean Society of Gastroenterology, and The Korean Pancreatobiliary Association.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
The doctor is a prominent figure in the field of surgery, holding leadership roles such as Director of the Training and Education Committee at the Korean Surgical Society and Director of the Information Technology Committee at the Korean Society of Coloproctology. The doctor also serves as Director of the Surgical Affairs Board at the Korean Society of Gastroenterology and Vice President of the Korean Association of Robotic Surgeons.
With a robust educational background from Korea University, the doctor has demonstrated surgical expertise internationally, including at the Faculty of Medicine, Chinese University of Hong Kong, and Tan Tock Seng Hospital in Singapore.
South Korea is a top choice for gallbladder cancer due to its 32.1% five-year survival rate. High regional prevalence means surgeons perform massive volumes of complex hepatobiliary resections. Major centers like Samsung Medical Center and Asan Medical Center rank among the world's best for oncology.
Bookimed Expert Insight: Patient volume is the strongest indicator of quality here. Severance Hospital and Samsung Medical Center serve millions of patients annually. This massive scale allows surgeons to specialize in rare biliary variations that doctors in lower-volume regions rarely encounter. Choosing these high-traffic Seoul centers ensures your surgeon likely manages dozens of similar cases every month.
Patient Consensus: Patients note that the speed of the workup is impressive. They value moving from initial scans to the operating room much faster than in other medical systems.
South Korea houses elite oncology centers specialized in hepatobiliary cancers. Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital (SNUH) lead the nation in gallbladder care. These JCI-accredited facilities utilize advanced robotic surgery and proton therapy to manage complex malignancies with high precision.
Bookimed Expert Insight: While patients often seek brand names, our data shows a clear advantage in volume at Asan and Samsung. These centers manage over 45,000 surgeries annually. This massive throughput ensures their hepatobiliary teams handle more rare gallbladder cases than smaller regional clinics. Choosing these high-volume hubs leads to better surgical accuracy due to the repetitive experience of their specialized staff.
Patient Consensus: Patients note it is essential to look for hospitals with dedicated hepatobiliary teams. They emphasize that rapid staging and surgery coordination are more important than convenience since this cancer often requires fast action.
Korean oncology centers treat gallbladder cancer with aggressive protocols centered on surgical resection and systemic therapies. Specialists utilize JCI-accredited facilities to perform radical cholecystectomies and advanced robotic surgeries. Multidisciplinary teams integrate digital imaging and biomarker-targeted therapies to improve patient outcomes in complex cases.
Bookimed Expert Insight: Clinical data shows a high-volume trend at centers like Samsung Medical Center, which handles over 2,000,000 patients annually. This massive scale suggests that Korean surgeons often manage more gallbladder cases than Western counterparts. This experience is vital for achieving R0 resection margins during difficult liver-bed surgeries.
Patient Consensus: Patients note that Korean doctors move quickly to surgery if the tumor appears operable. They suggest confirming whether a plan includes liver and lymph node removal before starting.
South Korean clinics report a 5-year relative survival rate of 32.1% for gallbladder cancer patients. This success stems from high-volume centers performing complex surgeries soon after diagnosis. Specialized oncology facilities in Seoul utilize robotic systems and proton therapy to manage difficult cases.
Bookimed Expert Insight: Patient volume is a reliable indicator of surgical proficiency in Korea. Asan Medical Center treats over 2,500 inpatients daily and maintains a 90% success rate in organ transplants. This high procedural density suggests that surgeons here encounter complex gallbladder cases more frequently than those at smaller regional centers.
Patient Consensus: Many patients find that the success of their treatment depends almost entirely on whether the tumor was caught early enough for complete surgical removal. They often stress getting scans done quickly because gallbladder cancer is frequently discovered at an advanced stage.
Referral requirements for gallbladder cancer specialists in South Korea vary by hospital and insurance. International patients often self-refer by submitting medical records directly to tertiary centers. Local residents or those using specific health plans typically require a referral from a primary care physician to secure coverage.
Bookimed Expert Insight: Data shows that South Korea's top-tier hospitals are concentrated in Seoul and operate as high-capacity digital hubs. For example, Severance Hospital and Samsung Medical Center each manage over 2,000,000 patient visits annually. While individual clinic rules differ, submitting high-quality scans before arrival often bypasses redundant local testing. This allows specialists at digital-first hospitals like Seoul National University Bundang Hospital to plan surgery immediately upon your arrival.
Patient Consensus: Patients note that while self-referral is possible, a summary letter from a local doctor speeds up the scheduling process. Organizing all pathology reports and finding a translator or coordinator helps navigate the intake systems at large Korean cancer centers.